Asymptomatic transmission and the resurgence of Bordetella pertussis

BMC Medicine

Volumn 13, Issue 1, 2015, Pages

  Althouse, Benjamin M ^a   Scarpino, Samuel V ^a  

^a SANTA FE INSTITUTE   (United States)

Author keywords

Asymptomatic infection; Bordetella pertussis; Phylodynamic analysis; Stochastic disease dynamical modeling; Vaccination policy; Whooping cough

Indexed keywords

PERTUSSIS VACCINE;

AGE; ARTICLE; ASYMPTOMATIC INFECTION; BACTERIAL TRANSMISSION; BACTERIUM ISOLATE; GENETIC VARIABILITY; HUMAN; IMMUNITY; INCIDENCE; INFECTION RATE; PERTUSSIS; PUBLIC HEALTH; UNITED KINGDOM; UNITED STATES; VACCINATION; BORDETELLA PERTUSSIS; CHILD; INFANT; MALE; PROCEDURES; THEORETICAL MODEL; TRANSMISSION; WHOOPING COUGH;

BORDETELLA PERTUSSIS; CHILD; HUMANS; INCIDENCE; INFANT; MALE; MODELS, THEORETICAL; PERTUSSIS VACCINE; UNITED KINGDOM; UNITED STATES; VACCINATION; WHOOPING COUGH;

EID: 84933509784     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-015-0382-8     Document Type: Article

References (72)

1. Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect. 2013; 142:1-13.
2. CDC Pertussis (Whooping Cough) Surveillance & Reporting. http://www.cdc.gov/pertussis/surv-reporting.html.
3. Office for National Statistics, UK, Datasets and reference tables. http://www.ons.gov.uk/ons/datasets-and-tables/index.html.
4. Águas R, Gonçalves G, Gomes MGM. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis. 2006; 6:112-7.
5. World Health Organization. Progress Towards Global Immunization Goals - 2012. http://www.unicef.org/immunization/files/SlidesGlobalImmunization.pdf.
6. Gambhir M, Clark TA, Cauchemez S, Tartof SY, Swerdlow DL, Ferguson NM. A Change in Vaccine Efficacy and Duration of Protection Explains Recent Rises in Pertussis Incidence in the United States. PLoS Comput Biol. 2015; 11:e1004138. doi:10.1371/journal.pcbi.1004138.
7. Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog. 2009; 5:1000647.
8. Mooi FR, Van Loo I, King AJ. Adaptation of Bordetella pertussis to vaccination: a cause for its reemergence?Emerg Infect Dis. 2001; 7:526.
9. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci. 2014; 111:787-92.
10. Storsaeter J, Hallander H, Farrington CP, Olin P, Möllby R, Miller E. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine. 1990; 8:457-61.
11. Von Linstow ML, Pontoppidan PL, von König C-HW, Cherry JD, Hogh B. Evidence of Bordetella pertussis infection in vaccinated 1-year-old Danish children. Eur J Pediatr. 2010; 169:1119-22.
12. Zhang Q, Yin Z, Li Y, Luo H, Shao Z, Gao Y, et al.Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study. Scand J Infect Dis. 2014; 46:280-7.
13. de Melker HE, Versteegh FG, Schellekens JF, Teunis PF, Kretzschmar M. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006; 53:106-13.
14. Cortese MM, Baughman AL, Brown K, Srivastava P. A "new age" in pertussis prevention: new opportunities through adult vaccination. Am J Prev Med. 2007; 32:177-85.
15. Domenech de Cellès M, Riolo MA, Magpantay FMG, Rohani P, King AA. Epidemiological evidence for herd immunity induced by acellular pertussis vaccines. Proc Natl Acad Sci USA. 2014; 111:E716-E717. doi:10.1073/pnas.1323795111 .
16. Warfel JM, Merkel TJ. Reply to Domenech de Cellès et al.: infection and transmission of pertussis in the baboon model. Proc Natl Acad Sci.; 111:718.
17. CDC Pertussis Surveillance & Reporting. http://www.cdc.gov/pertussis/surv-reporting.html.
18. Public Health England, Whooping cough (pertussis) statistics. https://www.gov.uk/government/publications/whooping-cough-pertussis-statistics.
19. Office for National Statistics, UK, Datasets and reference tables. http://www.ons.gov.uk/ons/datasets-and-tables/index.html.
20. Project Tycho. http://www.tycho.pitt.edu . copyright 2013, and it was last accessed June 2nd, 2014.
21. van Panhuis WG, Grefenstette J, Jung SY, Chok NS, Cross A, Eng H, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013; 369:2152-158.
22. Hethcote HW. An age-structured model for pertussis transmission. Math Biosci. 1997; 145:89-136.
23. Keeling MJ, Rohani P. Modeling infectious diseases in humans and animals. Princeton: Princeton University Press; 2008. http://www.loc.gov/catdir/toc/fy0805/2006939548.html.
24. Anderson RM, May RM, Vol. 28. Infectious diseases of humans: dynamics and control. New York, NY: Wiley Online Library: Oxford University Press; 1992.
25. Edwards KM. Unraveling the challenges of pertussis. Proc Natl Acad Sci. 2014; 111:575-6.
26. Althouse BM, Bergstrom TC, Bergstrom CT. A public choice framework for controlling transmissible and evolving diseases. Proc Natl Acad Sci U S A. 2010; 107 Suppl 1:1696-701. doi:10.1073/pnas.0906078107 .
27. Tanaka MM, Althouse BM, Bergstrom CT. Timing of antimicrobial use influences the evolution of antimicrobial resistance during disease epidemics. Evol Med Publ Health. 2014; 2014:150-61.
28. Gillespie DT. Exact stochastic simulation of coupled chemical reactions. J Phys Chem. 1977; 81:2340-2361.
29. Chatterjee A, Vlachos DG, Katsoulakis MA. Binomial distribution based tau-leap accelerated stochastic simulation. J Chem Phys. 2005; 122:024112. doi:10.1063/1.1833357 .
30. Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, et al. Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. mBio. 2014;5:01074-14.
31. Bouckaert R, Heled J, Kühnert D, Vaughan T, Wu CH, Xie D, et al.BEAST 2: a software platform for Bayesian evolutionary analysis. PLoS Comput Biol. 2014; 10:1003537.
32. Darriba D, Taboada GL, Doallo R, Posada D. jModelTest 2: more models, new heuristics and parallel computing. Nat Methods. 2012; 9:772-2.
33. Stadler T, Kühnert D, Bonhoeffer S, Drummond AJ. Birth-death skyline plot reveals temporal changes of epidemic spread in HIV and hepatitis C virus (HCV). Proc Natl Acad Sci. 2013; 110:228-33.
34. Drummond AJ, Ho SY, Phillips MJ, Rambaut A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 2006; 4:88.
35. Castagnini LA, Healy CM, Rench MA, Wootton SH, Munoz FM, Baker CJ. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012; 54:78-84.
36. Healy CM, Rench MA, Wootton SH, Castagnini LA. Evaluation of the impact of a pertussis cocooning program on infant pertussis infection. Pediatr Infect Dis J. 2015; 34:22-6.
37. Miller E, Gay N. Epidemiological determinants of pertussis. Dev Biol Stand. 1996; 89:15-23.
38. Gay NJ, Miller E. Pertussis transmission in England and Wales. The Lancet. 2000; 355:1553.
39. Rohani P, Earn DJ, Grenfell BT. Reply to Pertussis transmission in England and Wales. The Lancet. 2000; 355:1553-4.
40. for Disease Control C. Prevention: Case definitions for infectious conditions under public health surveillance. MMWR. 1997; 46:1-55.
41. Shakib J, Wyman L, Gesteland P, Staes C, Bennion D, Byington C. Should the pertussis case definition for public health reporting be refined?. J Public Health Manag Pract. 2009; 15:479-84.
42. Cherry JD. Epidemic pertussis in 2012-the resurgence of a vaccine-preventable disease. N Engl J Med. 2012; 367:785-7.
43. Bartlett M. The critical community size for measles in the United States. J R Stat Soc Ser A (General). 1960; 123:37-44.
44. Rohani P, Earn DJ, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. The Lancet. 2000; 355:285-6.
45. Rendi-Wagner P, Tobias J, Moerman L, Goren S, Bassal R, Green M, et al.The seroepidemiology of Bordetella pertussis in Israel-estimate of incidence of infection. Vaccine. 2010; 28:3285-90. doi:10.1016/j.vaccine.2010.02.104 .
46. CDC Pertussis (Whooping Cough) Surveillance & Reporting. http://www.cdc.gov/pertussis/surv-reporting.html.
47. van Boven M, Mooi FR, Schellekens JF, de Melker HE, Kretzschmar M. Pathogen adaptation under imperfect vaccination: implications for pertussis. Proc R Soc B Biol Sci. 2005; 272:1617-24.
48. van Boven M, de Melker HE, Schellekens JF, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in the Netherlands. Math Biosci. 2000; 164:161-82.
49. Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J. 2005; 24:58-61.
50. Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci. 2011; 108:7259-7264.
51. Goldwyn EE, Rohani P. Bias in pertussis incidence data and its implications for public health epidemiology. J Public Health Manag Pract. 2013; 19:379-82.
52. Güri D, Strebel PM, Bardenheier B, Brennan M, Tachdjian R, Finch E, et al. Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis. 1999; 28:1230-7.
53. Lam C, Octavia S, Ricafort L, Sintchenko V, Gilbert GL, Wood N, et al. Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia. Emerg Infect Dis. 2014; 20:626.
54. Mutua MK, Kimani-Murage E, Ettarh RR. Childhood vaccination in informal urban settlements in Nairobi, Kenya: who gets vaccinated?BMC Public Health. 2011; 11:6.
55. Bentsi-Enchill AD, Halperin SA, Scott J, MacIsaac K, Duclos P. Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population. Vaccine. 1997; 15:301-6.
56. Queenan AM, Cassiday PK, Evangelista A. Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med. 2013; 368:583-4.
57. Warfel JM, Beren J, Merkel TJ. Airborne transmission of Bordetella pertussis. J Infect Dis. 2012; 206:902-906.
58. Althouse BM, Hébert-Dufresne L. Epidemic cycles driven by host behaviour. J R Soc Interface. 2014; 11:20140575.
59. De Graaf W, Kretzschmar M, Teunis P, Diekmann O. A two-phase within-host model for immune response and its application to serological profiles of pertussis. Epidemics. 2014; 9:1-7.
60. Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence?Vaccine. 2013; 31:5903-8.
61. Locht C, Mielcarek N. Live attenuated vaccines against pertussis. Expert Rev Vaccines. 2014; 13:1147-58.
62. Meade BD, Plotkin SA, Locht C. Possible options for new pertussis vaccines. J Infect Dis. 2014; 209:24-7.
63. Abu Raya B, Srugo I, Kessel A, Peterman M, Bader D, Gonen R, et al.The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels-a prospective study. Vaccine. 2014; 32:5787-5793.
64. Munoz FM, Bond NH, Maccato M, Pinell P, Hammill HA, Swamy GK, et al.Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial. JAMA: J Am Med Assoc. 2014; 311:1760-9.
65. Sheridan SL, Ware RS, Grimwood K, Lambert SB. Number and order of whole cell pertussis vaccines in infancy and disease protection. JAMA. 2012; 308:454-6.
66. Liko J, Robison SG, Cieslak PR. Priming with whole-cell versus acellular pertussis vaccine. N Engl J Med. 2013; 368:581-2.
67. Witt MA, Arias L, Katz PH, Truong ET, Witt DJ. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort. Clin Infect Dis. 2013; 56:1248-1254.
68. Fine PE, Carneiro IA. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. Am J Epidemiol. 1999; 150:1001-21.
69. Plotkin SA. The pertussis problem. Clin Infect Dis. 2013; 58:830-833.
70. Public Health England, Whooping cough (pertussis) statistics. https://www.gov.uk/government/publications/whooping-cough-pertussis-statistics.
71. Anderson R, May R. Immunisation and herd immunity. Lancet. 1990; 335:641-5.
72. Kretzschmar M, Teunis PF, Pebody R. G. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med. 2010; 7:1000291.